0 Commentaires
0 Parts
565 Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Connectez-vous pour aimer, partager et commenter!
-
Emerging Vaccines for Ebola: Global Market OverviewWhat is the projected growth rate (CAGR) of the Ebola *** Vaccine Market from 2024 to 2031, and what is the market value expected to change by 2031? The Global Ebola *** Vaccine Market reached US$173.82 million in 2024 and is expected to reach US$288.41 million by 2033, growing at a CAGR of 6.4 % during the forecast period 2025-2033. What is the Ebola *** Vaccine Market? The Ebola *** Vaccine...0 Commentaires 0 Parts 2KB Vue 0 Aperçu
-
Global Demand for Inactivated Vaccines: Trends and InsightsWhat is the projected growth rate (CAGR) of the Inactivated Vaccines Market from 2024 to 2031, and what is the market value expected to change by 2031? The Global Inactivated Vaccines Market reached US$22.60 billion in 2024 and is expected to reach US$34.26 billion by 2033, growing at a CAGR of 4.8% during the forecast period 2024-2032. What is the Inactivated Vaccines Market? This market...0 Commentaires 0 Parts 2KB Vue 0 Aperçu
-
Harnessing mRNA Technology: Transforming Vaccines and Therapeutic InnovationsThe emergence of mRNA-based vaccines has revolutionized global healthcare by demonstrating rapid adaptability and effective immune response. Unlike conventional vaccines, these therapies instruct cells to produce antigens, triggering immunity without using live pathogens. This breakthrough has positioned mRNA therapies as a transformative force in the vaccines and therapeutics landscape....0 Commentaires 0 Parts 634 Vue 0 Aperçu
-
Inactivated Vaccines Market Share and Future Scope“Global Inactivated Vaccines Market reached US$22.60 billion in 2024 and is expected to reach US$34.26 billion by 2033, growing at a CAGR of 4.8% during the forecast period 2024-2032”, according to DataM intelligence report. Inactivated vaccines are created by *** the disease-causing microorganisms using heat, chemicals, or radiation. Unlike live vaccines, these do not...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
Live Attenuated Vaccines Market Report | CAGR 6.6% Driven by Preventive Healthcare Awareness & Key Growth SegmentsThe live attenuated vaccines market plays a pivotal role in global immunization strategies. By leveraging weakened pathogens viral or bacterial to induce robust and durable immune responses, these vaccines provide advantages like long-term protection with fewer doses. They are vital in fighting diseases such as measles, oral polio, rotavirus, tuberculosis, yellow fever, and some less common...0 Commentaires 0 Parts 554 Vue 0 Aperçu
-
mRNA Vaccines Redefined: CI Insights into Innovation, Platforms, and Market ExpansionMessenger RNA (mRNA) vaccines have emerged as a transformative force in the global fight against infectious diseases, with their rapid development, adaptability, and precision mechanism driving a new era of preventive medicine. Once considered experimental, mRNA technology now stands at the forefront of vaccine innovation, with expanding applications in infectious disease, oncology, and...0 Commentaires 0 Parts 2KB Vue 0 Aperçu
-
Next-Generation Ebola Vaccine Market Outlook: Thermostable Formulations, Combination Vaccines, and Global Health Security InitiativesThe global Ebola virus vaccine market size reached US$173.82 million in 2024 and is expected to reach US$288.41 million by 2033, growing at a CAGR of 6.4 % during the forecast period 2025-2033, according to DataM Intelligence. This robust growth is propelled by ongoing outbreak preparedness initiatives, increasing government stockpiling, and continued development of...0 Commentaires 0 Parts 549 Vue 0 Aperçu
-
USDA’s Poultry Vaccine Plan Accelerates USD 12B+ Veterinary Vaccines IndustryThe global veterinary vaccines market is entering a phase of sustained growth and innovation, with mounting demand from both companion animal and livestock sectors. According to recent data, market valuation reached USD 12.05 billion in 2024 and is forecast to climb to USD 12.51 billion in 2025 and USD ***56 billion by 2032, reflecting a compound annual growth rate (CAGR) of 5.8%. Meanwhile,...0 Commentaires 0 Parts 2KB Vue 0 Aperçu
-
Veterinary Vaccines Market Size & Global Trends Forecast Report by 2025According to Straits Research the global veterinary vaccines market size was valued at USD 12.32 billion in 2024 and is expected to reach USD 22.54 billion in 2033, growing at a CAGR of 6.94% during the forecast period (2025–2033). The central objective of this study is to define and quantify the global Veterinary Vaccines market...0 Commentaires 0 Parts 372 Vue 0 Aperçu
-
Global Immunization Growth Powers Live Attenuated Vaccine DemandThe Live Attenuated Vaccines Market is experiencing rapid expansion, projected to grow from USD 25.3 billion in 2023 to USD 70.4 billion by 2032. The market is driven by increased demand for robust, long-lasting immunizations, innovations in oral and intranasal delivery systems, and rising infectious disease threats worldwide. Growth is especially strong in the United States, Japan, and across...0 Commentaires 0 Parts 2KB Vue 0 Aperçu
-
Global Oropouche Fever Market Outlook: Emerging Trends and OpportunitiesThe market for the disease known as Oropouche fever caused by the Oropouche virus (OROV) is rapidly gaining attention from public-health authorities, biotech companies, diagnostics players and pharmaceutical manufacturers. Historically considered a localized arboviral disease in the Amazon and select regions of South America, recent outbreaks and geographic expansion have prompted...0 Commentaires 0 Parts 304 Vue 0 Aperçu
-
Screening & Awareness Initiatives Bolster Hepatitis B *** UptakeThe global Hepatitis B Treatment Market is positioned for consistent growth, with market valuation expected to increase from USD 4.5 billion in 2023 to USD 7.3 billion by 2032, growing at a CAGR of 5.9% during the forecast period (2024–2032). The rise in chronic hepatitis B cases globally, combined with growing awareness, treatment accessibility, and a strong pipeline of advanced...0 Commentaires 0 Parts 2KB Vue 0 Aperçu
-
Viral Vector Vaccines Market to Surpass USD 2.6 Billion by 2032: Key Players, Segments, and Growth ForecastThe global Viral Vector Vaccines Market was valued at USD 850.43 million in 2024 and is expected to grow at a CAGR of 15.93% between 2025 and 2032. Fueled by rising infectious disease prevalence and innovations in genetic engineering, viral vector vaccines have become critical tools in modern immunology. According to a recent report by AnalystView Market Insights (Report Code: AV4115), this...0 Commentaires 0 Parts 2KB Vue 0 Aperçu
Plus de résultats
Commandité
Commandité
© 2025 Friends - Best Social Network - החברים - רשת חברתית
French
French
English
Arabic
עברית
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek